{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Should I Call a Doctor?","title":"#12: Finding lung cancer earlier – for smokers and nonsmokers","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/88390439\"></iframe>","width":"100%","height":180,"duration":1715,"description":"What you’ll learn:\nShould smokers and nonsmokers be screened for lung cancer? Inova Schar Cancer’s Dr. Mahajan explains what you should know about lung cancer screening, your personal history and risk factors, and groundbreaking early detection and treatment options – so you can take charge of your health.\n \nFeatured guest:\nDr. Amit “Bobby” Mahajan, \nMedical Director, Interventional Pulmonology \nInova Schar Cancer\n \nKey takeaways with chapter markers:\nHow age and smoking history guide screening [5:46-6:27]\nInterventional pulmonology [3:31]\nHow lung cancer treatment is advancing [3:52]\nEarly-stage lung cancer does not have symptoms, making detection of lung nodules critical [4:35 – 5:13]\nA growing number of nonsmokers are developing lung cancer. [6:59 – 7:18]\nThose with EGFR gene mutations have a higher instance of developing lung cancer [7:30 – 8:08]\nThose who have a family member who has had a nonsmoking lung cancer should also get screened [9:49 – 10:05]\nInova offers a low-cost screening option. [10:16 – 10:35]\nIn five years, over 10,000 incidental nodules were detected by Inova’s incidental lung nodule program. 1-2% were cancerous, the program helps diagnose more early stage lung cancer cases [13:30 – 15:33]\nMutation analysis is key to better treatment. There are seven or eight mutations that are really actionable [16:55 – 17:14]\nEarly-stage lung cancer can be treated with minimally invasive options, with exceptional survival rates. [18:02 – 18:10]\nInova’s incidental lung nodule detection program streamlines care and dramatically reduces the time between detection and treatment [25:55-27:47]\nFAQs\n\nWhat is lung cancer screening?\nAnnual lung cancer screening uses low-dose computed tomography (LDCT) to detect cancer in its earliest, most treatable stage. LDCT technology generates cross-sectional images of the body, using less ionizing radiation than a conventional CT scan.\n \nWho should be screened for lung cancer?\nAnnual lung cancer screening is recommended for...","thumbnail_url":"https://img.transistorcdn.com/rIhAE1Yjj7iH2WXU7Cj8xeYhrKhDvvmcDg0CL_qiPZo/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83YmIx/NDcxNDI2NzI4Y2M4/Zjc2MjM2NTdmZDEz/YzQ3Ni5qcGVn.webp","thumbnail_width":300,"thumbnail_height":300}